CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,020,980 | +9.2% | 359,500 | 0.0% | 0.01% | +20.0% |
Q2 2023 | $934,700 | +42.9% | 359,500 | 0.0% | 0.01% | +25.0% |
Q1 2023 | $654,290 | +10.3% | 359,500 | 0.0% | 0.00% | +33.3% |
Q4 2022 | $593,175 | -14.0% | 359,500 | 0.0% | 0.00% | -25.0% |
Q3 2022 | $690,000 | -35.8% | 359,500 | 0.0% | 0.00% | -76.5% |
Q2 2022 | $1,075,000 | – | 359,500 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OUP Management Co., LLC | 2,459,572 | $6,985,184 | 15.71% |
BML Capital Management, LLC | 3,250,008 | $9,230,023 | 8.48% |
Newtyn Management, LLC | 2,500,444 | $7,101,261 | 1.75% |
VR Advisory Services Ltd | 1,072,968 | $3,047,229 | 1.08% |
Anson Funds Management LP | 1,324,114 | $3,760,484 | 0.76% |
Acuitas Investments, LLC | 329,164 | $934,826 | 0.55% |
Aldebaran Capital, LLC | 143,739 | $408,219 | 0.42% |
Bulldog Investors, LLP | 200,000 | $568,000 | 0.20% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 416,200 | $1,182,008 | 0.19% |
Alta Fundamental Advisers LLC | 117,346 | $333,263 | 0.16% |